Methodology · Private Equity · Confirmatory Diligence | Aug 4, 2026 | 7 min read
You are twenty-two days into a forty-five-day exclusivity period.
The Confidential Information Memorandum states $12.4M of adjusted EBITDA. Your Quality of Earnings provider has the data room, but the draft is two weeks out. Meanwhile, the seller’s banker is asking whether you are holding your indicated multiple.
Here is what you actually have: a number you cannot yet defend, a ticking clock, and a bridge from reported EBITDA to adjusted EBITDA that runs eleven line items long.
Every one of those eleven lines is an argument. Not a fact. And you are about to pay an 8x multiple on all of them.
Why does the CIM’s EBITDA rarely survive contact with the ledger?
Because an add-back is fundamentally a narrative vehicle.
When a seller adds back $340,000 of legal expense as “non-recurring,” they are not describing history. The money left the business; the event happened. What they are asserting is that it will not happen again — that this cost belongs to a version of the company that no longer exists.
It is worth being precise about what this is, because the distinction governs how you defend against it. This is not a hallucination. A hallucination is what a machine produces when it does not know. This is a fiction — a subjective assumption presented with the unearned confidence of arithmetic, authored by someone who knows exactly what they are doing.
By the time the number reaches the Investment Committee inside a clean schedule, the aggressive arguments that produced it have been laundered out of view.
The asymmetry of the multiple
When add-backs are discussed merely as accounting exercises, the structural danger is ignored. Add-backs do not enter a deal at face value. They enter at the multiple.
At an 8x multiple, a $500,000 add-back that fails to survive post-close scrutiny is not a $500,000 accounting error. It is a $4 million equity mistake, paid for earnings that never existed.
Now run that math across a buy-and-build. Six add-on acquisitions in eighteen months, each with its own bridge, none individually large enough to justify a $100,000 QoE engagement. The error compounds directly into the platform’s adjusted EBITDA at exit — where a sophisticated buyer’s advisors will finally uncover it, and reprice it at their multiple.
Math does not change based on valuation, deal urgency, or how much the partnership already likes this asset.
The sequencing trap
The problem is not a lack of diligence. It is a fatal flaw in sequencing.
Deal teams are forced to commit to a price before the instrument that validates the price has finished running. Traditional QoE is expensive and slow; it cannot be deployed on every top-of-funnel look. Which means the deals requiring the most preliminary scrutiny are precisely the ones that receive the least.
The industry treats verification as a late-stage audit rather than as top-of-funnel infrastructure. That is backwards, and every deal partner already knows it.
Deploying deterministic verification
Closing this gap does not mean replacing the QoE. It means deploying verification before you sign exclusivity or wire a retainer.
A defensible add-back must hold three properties simultaneously:
- It is mathematically traceable. It maps to specific ledger entries, not to a summary schedule prepared by a sell-side advisor. A schedule is an assertion. The ledger is the record.
- It is historically non-recurring. It does not recur when you widen the timeline past the seller’s selected window. A legal settlement in FY24 is non-recurring. The same settlement in FY22, FY23 and FY24 is a cost of doing business, relabelled.
- The counterfactual survives. Remove the founder’s above-market salary and you must add back the cost of the market-rate executive required to do their job.
In the AI era, relying on junior associates to manually cross-examine the CIM against the ledger is an unscalable fiduciary risk. Using generic generative AI platforms is equally dangerous — they optimize for fluency, not truth. Feed one a CIM and it will summarize the seller’s fiction back to you as fact, wrapped in authoritative prose. That failure mode has a name: Narrative Masking.
This is why we architected askOdin.
We do not use AI to summarize the CIM. We deploy AI Judgment Infrastructure™ to cross-examine it.
Our RAVEN Triangulator interrogates the narrative across isolated files. If an adjusted EBITDA figure fails to reconcile identically across the CIM, the lender deck and the management presentation, our deterministic extraction pattern flags the discrepancy. It isolates the actual unit scales and anchors the math to an immutable Provenance Ledger.
The architectural mechanics of RAVEN’s triangulation engine are protected under U.S. Provisional Patent No. 63/994,876 and are not publicly disclosed.
A number can be assembled honestly by a sell-side advisor and still be structurally fatal to your returns.
The bridge from reported to adjusted is where the deal is actually priced. Verify the math before you buy the narrative.
Related reading: AI Quality of Earnings · CIM Analysis · PE Due Diligence